Squarticles as the nanoantidotes to sequester the overdosed antidepressant for detoxification

Area of Science:

• Pharmacology
• Nanotechnology
• Toxicology

Background:

• Rising drug overdose deaths necessitate novel detoxification therapies.
• Tricyclic antidepressant (TCA) overdose presents a significant clinical challenge.
• Lipid nanoemulsions offer potential as drug delivery and detoxification systems.

Purpose of the Study:

• To investigate the pharmacokinetic and pharmacodynamic effects of squarticles as a nanoantidote for amitriptyline (a TCA) intoxication.
• To evaluate squarticles' efficacy in mitigating TCA overdose adverse effects in an animal model.

Main Methods:

• Preparation and characterization of anionic and cationic squarticles (lipid nanoemulsions).
• In vitro drug entrapment and interaction studies (isothermal titration calorimetry).
• In vivo animal study using a rat model of amitriptyline poisoning, including real-time imaging.

Main Results:

• Squarticles demonstrated efficient entrapment of amitriptyline with low leakage.
• Anionic squarticles exhibited stronger interaction with amitriptyline and prolonged circulation.
• Anionic squarticles mitigated amitriptyline toxicity by reducing organ drug uptake, restoring blood pressure, and increasing survival rate from 25% to 75%.

Conclusions:

• Anionic squarticles act as a potent lipid nanoemulsion antidote for amitriptyline overdose.
• The "lipid sink" effect of squarticles facilitates drug redistribution and detoxification.
• This nanoemulsion therapy shows significant potential for managing TCA poisoning.